等待开盘 08-10 09:30:00 美东时间
-0.470
-0.50%
Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that REVTORPYK™ (gedatolisib) in combination with fulvestrant, with or without palbociclib, is recommended by the National Comprehe...
07-30 20:34
Source: TradePulse | July 15, 2026 Market Overview Recent aggregate flow data reflects continued institutional participation across several key market segments, with large-cap technology, financial services, healthcare, real estate, telecommunications, and exchange-traded funds represented within Tr...
07-16 20:15
今日重点评级关注:Needham:维持Annexon"买入"评级,目标价从11美元升至25美元;Benchmark:维持Prenetics Global"买入"评级,目标价从30美元升至40美元
07-16 18:55
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised the price target for Crowdstrike Holdings Inc (NASDAQ:CRWD) from $191 to $237. BTIG analyst Gray P...
07-15 21:06
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celcuity (NASDAQ:CELC) with a Buy and raises the price target from $145 to $155.
07-15 18:18
Aehr Test Systems涨30.95%;科休半导体涨6.67%;Wolfspeed Inc涨4.84%
07-15 10:01
Aehr Test Systems涨29.97%;科休半导体涨6.67%;Karman Holdings涨4.32%
07-15 09:01
The US FDA has approved Celcuity's (CELC) Revtorpyk (gedatolisib) in combination with fulvestrant, with or without palbociclib, for HR+/HER- breast cancer following one line of endocrine therapy. Appr...
07-15 04:58
维多利亚的秘密周涨超35%!财报及业绩指引均超预期;迈威尔科技周涨超28%,此前获黄仁勋“喊单”!称其有望晋级万亿美元市值;传奇生物周涨超20%,CAR-T细胞疗法实验数据引爆市场>>
06-06 11:25